Cargando…

Emergency intensive care unit pharmacist’s intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study

BACKGROUND: Four-factor prothrombin complex concentrate (4F-PCC) must be administered as soon as possible, and in our emergency intensive care unit (EICU), pharmacists are available on weekdays for consultation on expediting 4F-PCC administration. Although recent reports have described a reduction i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imanaka, Shoichi, Kuwabara, Tatsuro, Ikeda, Hiroto, Miyake, Yasufumi, Enomoto, Hiromi, Sakamoto, Tetsuya, Yasuno, Nobuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118855/ https://www.ncbi.nlm.nih.gov/pubmed/32266076 http://dx.doi.org/10.1186/s40780-020-00161-z

Ejemplares similares

Evaluation of factors related to overdose in patients with impaired consciousness who are transported by emergency medical services: an age-specific research
por: Nagashima, Kazuki, et al.
Publicado: (2021)

Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage
por: Corio, Jessica L., et al.
Publicado: (2018)

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

Three- versus four-factor prothrombin complex concentrate for the reversal of warfarin-induced bleeding
por: Holt, Tara, et al.
Publicado: (2018)

Reversibility of Apixaban Anticoagulation with a Four‐Factor Prothrombin Complex Concentrate in Healthy Volunteers
por: Nagalla, S, et al.
Publicado: (2016)

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
por: Schenk, Bettina, et al.
Publicado: (2018)

Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
por: Naeem, Zaina, et al.
Publicado: (2021)

Emergency trauma laparotomy and/or thoracotomy in the emergency department: risks and benefits
por: Ito, Kaori, et al.
Publicado: (2019)

PROTHROMBIN COMPLEX CONCENTRATE  IN EMERGENCY DEPARTMENT
por: Nesek Adam, Višnja, et al.
Publicado: (2022)

Pre hospital administration of prothrombin complex concentrate in the head injured patient, a service evaluation
por: Lendrum, RA, et al.
Publicado: (2013)

Perioperative prothrombin complex concentrate and fibrinogen administration are associated with thrombotic complications after liver transplant
por: Dehne, Sarah, et al.
Publicado: (2022)

Reversal of edoxaban-induced anticoagulation by the four-factor prothrombin complex concentrate Beriplex(® )in a rabbit model
por: Herzog, E, et al.
Publicado: (2014)

Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models
por: Ghosh, Subhajit, et al.
Publicado: (2021)

Erratum to “Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study”
Publicado: (2023)

Optimal Dosage and Administration Practices for Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate
por: Rhoney, Denise H., et al.
Publicado: (2020)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Prothrombin Complex Concentrates Only After Thromboelastography
por: Muggleton, Ellis, et al.
Publicado: (2019)

Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage
por: Herzog, E., et al.
Publicado: (2015)

Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
por: Rech, Megan A., et al.
Publicado: (2021)

High incidence of heat illness and the potential burden on the health care system during the COVID-19 pandemic
por: Nakahara, Shinji, et al.
Publicado: (2020)

A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
por: Sølbeck, Sacha, et al.
Publicado: (2012)

Evaluation of fixed dose four-factor prothrombin complex concentrate for warfarin reversal at a level 1 trauma center
por: Drone, H, et al.
Publicado: (2015)

Use of four‐factor prothrombin complex concentrate for the mitigation of rivaroxaban‐induced bleeding in an emergent coronary artery bypass graft
por: Liu, Michael, et al.
Publicado: (2017)

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)
por: Riess, H, et al.
Publicado: (2007)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

Role of prothrombin complex concentrate in the severe trauma patient
por: Egea-Guerrero, Juan José, et al.
Publicado: (2022)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
por: Mansory, Eman M., et al.
Publicado: (2021)

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
por: Bordeleau, Simon, et al.
Publicado: (2015)

Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM(®))-guided administration of fibrinogen concentrate and prothrombin complex concentrate
por: Schöchl, Herbert, et al.
Publicado: (2010)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal
por: Refaai, Majed A., et al.
Publicado: (2015)

Four-factor prothrombin complex concentrate (Beriplex® P/N) mediated reversal of apixaban-induced bleeding in a rabbit model
por: Herzog, E, et al.
Publicado: (2015)

Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review
por: Fukui, Shoichi, et al.
Publicado: (2015)

Retroperitoneal perforation of the descending colon diverticulitis presenting with systemic emphysema
por: Kono, Kaori, et al.
Publicado: (2020)

Novel score for predicting early emergency endovascular therapy in trauma care using logistic LASSO regression
por: Yokoyama, Taro, et al.
Publicado: (2022)

Pharmacist medication instructions are associated with continued medication self-management in older adults: a retrospective observational study
por: Kose, Eiji, et al.
Publicado: (2021)

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies
por: Balendran, Clare A., et al.
Publicado: (2017)

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

The role of prothrombin complex concentrates in reversal of target specific anticoagulants
por: Babilonia, Katrina, et al.
Publicado: (2014)

Using of prothrombin complex concentrate in patients with trauma-induced coagulopathy
por: Tarabrin, O, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p22nfsce1bgp6cjdte0597fnuc